Cargando…
Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry
Influenza A viruses (IAVs) cause seasonal pandemics and epidemics with high morbidity and mortality, which calls for effective anti-IAV agents. The glycoprotein hemagglutinin of influenza virus plays a crucial role in the initial stage of virus infection, making it a potential target for anti-influe...
Autores principales: | Wu, Wenjiao, Li, Richan, Li, Xianglian, He, Jian, Jiang, Shibo, Liu, Shuwen, Yang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728566/ https://www.ncbi.nlm.nih.gov/pubmed/26712783 http://dx.doi.org/10.3390/v8010006 |
Ejemplares similares
-
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
por: Jiang, Shibo, et al.
Publicado: (2010) -
New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides
por: Wu, Wenjiao, et al.
Publicado: (2015) -
A “building block” approach to the new influenza A virus entry inhibitors with reduced cellular toxicities
por: Lin, Dongguo, et al.
Publicado: (2016) -
Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2
por: Chen, Na, et al.
Publicado: (2022) -
Initial activation of STAT2 induced by IAV infection is critical for innate antiviral immunity
por: Li, Xinxin, et al.
Publicado: (2022)